Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Confo Therapeutics has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Confo Therapeutics's investors include Perceptive Advisors, Capricorn Partners, Wellington Partners, Qbic Fund, BioGeneration Ventures.
Confo Therapeutics is headquartered in Brussels, Belgium.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Confo Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Confo Therapeutics — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/confo-therapeutics. Accessed November 13, 2026.
VCBacked. (2025). Confo Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/confo-therapeutics
{{cite web |title=Confo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/confo-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Confo Therapeutics? Request a listing update